CLINICAL TRIALS PROFILE FOR PYRIDOSTIGMINE BROMIDE
✉ Email this page to a colleague
All Clinical Trials for PYRIDOSTIGMINE BROMIDE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00223691 ↗ | Treatment of Orthostatic Hypotension in Autonomic Failure | Completed | Vanderbilt University | Phase 1 | 2002-03-01 | The autonomic nervous system serves multiple regulatory functions in the body, including the regulation of blood pressure and heart rate, gut motility, sweating and sexual function. There are several diseases characterized by abnormal function of the autonomic nervous system. Medications can also alter autonomic function. Impairment of the autonomic nervous system by diseases or drugs may lead to several symptoms, including blood pressure problems (e.g., high blood pressure lying down and low blood pressure on standing), sweating abnormalities, constipation or diarrhea and sexual dysfunction. Because treatment options for these patients are limited. We propose to study patients autonomic failure and low blood pressure upon standing and determine the cause of their disease by history and examination and their response to autonomic testing which have already been standardized in our laboratory. Based on their possible cause, we will tests different medications that may alleviate their symptoms. |
| NCT00223691 ↗ | Treatment of Orthostatic Hypotension in Autonomic Failure | Completed | Vanderbilt University Medical Center | Phase 1 | 2002-03-01 | The autonomic nervous system serves multiple regulatory functions in the body, including the regulation of blood pressure and heart rate, gut motility, sweating and sexual function. There are several diseases characterized by abnormal function of the autonomic nervous system. Medications can also alter autonomic function. Impairment of the autonomic nervous system by diseases or drugs may lead to several symptoms, including blood pressure problems (e.g., high blood pressure lying down and low blood pressure on standing), sweating abnormalities, constipation or diarrhea and sexual dysfunction. Because treatment options for these patients are limited. We propose to study patients autonomic failure and low blood pressure upon standing and determine the cause of their disease by history and examination and their response to autonomic testing which have already been standardized in our laboratory. Based on their possible cause, we will tests different medications that may alleviate their symptoms. |
| NCT00953914 ↗ | Pyridostigmine and Its Effects on Autonomic Modulation in Diabetic Patients | Completed | Hospital de Clinicas de Porto Alegre | N/A | 2005-03-01 | The purpose of the study is to determine if pyridostigmine bromide improves heart rate variability of type 2 diabetes mellitus subjects with cardiovascular autonomic neuropathy. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PYRIDOSTIGMINE BROMIDE
Condition Name
Clinical Trial Locations for PYRIDOSTIGMINE BROMIDE
Trials by Country
Clinical Trial Progress for PYRIDOSTIGMINE BROMIDE
Clinical Trial Phase
Clinical Trial Sponsors for PYRIDOSTIGMINE BROMIDE
Sponsor Name
| Sponsor Name for PYRIDOSTIGMINE BROMIDE | |
| Sponsor | Trials |
| James J. Peters Veterans Affairs Medical Center | 2 |
| Vanderbilt University Medical Center | 2 |
| Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
